UG from Salem Government Mohan Kumaramangalam Medical College.
DNB degree (General Medicine) from National Board of Examinations, New Delhi
DM Neurology from the most famed Institute of Neurology at Madras Medical College, Chennai.
Received the prestigious American Academy of Neurology International Scholarship Award for research in 2018 held at Los Angeles, USA.
Received many awards for the outstanding platform paper presentation and poster presentation at conferences like IANCON and International Neuro Critical Care Conference.
He has done some innovative research in Decompressive Hemicraniectomy in malignant MCA infarct, Guillian- Barre syndrome and Bells palsy.
Special training in Botox injection procedure for movement disorders and post stroke status and also in reporting neurological investigations like EEG, EMG and NCS.
Contributed a chapter on ‘’Reviews on Multiple Sclerosis in India ‘’and also co-authored ‘’Anti-Neural antibodies and is disease association’’.
Active member of professional organizations including Indian Academy of Neurology (IAN) and American Academy of Neurology (AAN).
His aim is to give patient centered care and also he provides his patients with up to date information about their illness and the advanced treatment options available.
His interminable dedication to the patient’s well-being with his excellent diagnostic skills helps him to identify and treat several illnesses at its earliest stage with experience as a clinician.
EXPERIENCE:
Worked in the Department of Neurology at Sri Ramakrishna Hospital,Coimbatore.
Experience in handling acute neurological emergencies which include stroke, meningoencephalitis, autoimmune encephalitis and epilepsy as well as handling neuro ICU
Skilled in Neurophysiology testing procedures like Electroencephalograms, Nerve conduction studies and electromyography.
Worked as an ICU consultant in a reputed private hospital , Chennai for 2 years.
SPECIAL AREA OF INTEREST
Acute stroke intervention and thrombolysis
Neurological emergencies
Movement disorders including Parkinson’s disease and Botulinum toxin therapy
